Cargando…

A Double-Blind Randomized Placebo-Controlled Study Assessing the Safety, Tolerability and Efficacy of a Herbal Medicine Containing Pycnogenol Combined with Papain and Aloe vera in the Prevention and Management of Pre-Diabetes

Background: Herbal medicines present attractive options to patients with chronic diseases. Undertaking clinical studies with patients presenting with symptomless pre-T2D can lead to significant limitations. Methods: A 12-week randomized double-blind placebo-controlled clinical study was conducted th...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitetta, Luis, Butcher, Belinda, Dal Forno, Serena, Vitetta, Gemma, Nikov, Tessa, Hall, Sean, Steels, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235750/
https://www.ncbi.nlm.nih.gov/pubmed/32331307
http://dx.doi.org/10.3390/medicines7040022
_version_ 1783536027056472064
author Vitetta, Luis
Butcher, Belinda
Dal Forno, Serena
Vitetta, Gemma
Nikov, Tessa
Hall, Sean
Steels, Elizabeth
author_facet Vitetta, Luis
Butcher, Belinda
Dal Forno, Serena
Vitetta, Gemma
Nikov, Tessa
Hall, Sean
Steels, Elizabeth
author_sort Vitetta, Luis
collection PubMed
description Background: Herbal medicines present attractive options to patients with chronic diseases. Undertaking clinical studies with patients presenting with symptomless pre-T2D can lead to significant limitations. Methods: A 12-week randomized double-blind placebo-controlled clinical study was conducted that investigated the safety and efficacy of an herbal formulation administered orally for the treatment of pre-type 2 diabetes (pre-T2D). Results: A numerically greater proportion of subjects in the interventional arm had impaired fasting glucose (IFG) at week 12 compared to the control arm (71.0% vs. 69.0%, p = 0.75). Fewer participants had impaired glucose tolerance (IGT) at 12 weeks in the intervention arm compared to the control arm (unadjusted 58.3% vs. 66.7%, p = 0.65; adjusting for baseline IGT, p = 0.266). In a subgroup analysis, subjects with a baseline fasting plasma glucose (FPG) level in the range of 6.1–6.9 mmol/L demonstrated a non-significant lower proportion of IFG at week 12 in the intervention arm compared to the control arm (60.0% vs. 41.7% p = 0.343). Total blood cholesterol and triglyceride levels remained unchanged from baseline to week 12 in both treatment groups. Conclusions: This study suggests that a polyherbal medicine was not effective for reducing the metabolic markers associated with pre-T2D over a 12-week period. Therefore, larger studies with well-defined endpoints and of longer duration are warranted.
format Online
Article
Text
id pubmed-7235750
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72357502020-05-22 A Double-Blind Randomized Placebo-Controlled Study Assessing the Safety, Tolerability and Efficacy of a Herbal Medicine Containing Pycnogenol Combined with Papain and Aloe vera in the Prevention and Management of Pre-Diabetes Vitetta, Luis Butcher, Belinda Dal Forno, Serena Vitetta, Gemma Nikov, Tessa Hall, Sean Steels, Elizabeth Medicines (Basel) Article Background: Herbal medicines present attractive options to patients with chronic diseases. Undertaking clinical studies with patients presenting with symptomless pre-T2D can lead to significant limitations. Methods: A 12-week randomized double-blind placebo-controlled clinical study was conducted that investigated the safety and efficacy of an herbal formulation administered orally for the treatment of pre-type 2 diabetes (pre-T2D). Results: A numerically greater proportion of subjects in the interventional arm had impaired fasting glucose (IFG) at week 12 compared to the control arm (71.0% vs. 69.0%, p = 0.75). Fewer participants had impaired glucose tolerance (IGT) at 12 weeks in the intervention arm compared to the control arm (unadjusted 58.3% vs. 66.7%, p = 0.65; adjusting for baseline IGT, p = 0.266). In a subgroup analysis, subjects with a baseline fasting plasma glucose (FPG) level in the range of 6.1–6.9 mmol/L demonstrated a non-significant lower proportion of IFG at week 12 in the intervention arm compared to the control arm (60.0% vs. 41.7% p = 0.343). Total blood cholesterol and triglyceride levels remained unchanged from baseline to week 12 in both treatment groups. Conclusions: This study suggests that a polyherbal medicine was not effective for reducing the metabolic markers associated with pre-T2D over a 12-week period. Therefore, larger studies with well-defined endpoints and of longer duration are warranted. MDPI 2020-04-22 /pmc/articles/PMC7235750/ /pubmed/32331307 http://dx.doi.org/10.3390/medicines7040022 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Vitetta, Luis
Butcher, Belinda
Dal Forno, Serena
Vitetta, Gemma
Nikov, Tessa
Hall, Sean
Steels, Elizabeth
A Double-Blind Randomized Placebo-Controlled Study Assessing the Safety, Tolerability and Efficacy of a Herbal Medicine Containing Pycnogenol Combined with Papain and Aloe vera in the Prevention and Management of Pre-Diabetes
title A Double-Blind Randomized Placebo-Controlled Study Assessing the Safety, Tolerability and Efficacy of a Herbal Medicine Containing Pycnogenol Combined with Papain and Aloe vera in the Prevention and Management of Pre-Diabetes
title_full A Double-Blind Randomized Placebo-Controlled Study Assessing the Safety, Tolerability and Efficacy of a Herbal Medicine Containing Pycnogenol Combined with Papain and Aloe vera in the Prevention and Management of Pre-Diabetes
title_fullStr A Double-Blind Randomized Placebo-Controlled Study Assessing the Safety, Tolerability and Efficacy of a Herbal Medicine Containing Pycnogenol Combined with Papain and Aloe vera in the Prevention and Management of Pre-Diabetes
title_full_unstemmed A Double-Blind Randomized Placebo-Controlled Study Assessing the Safety, Tolerability and Efficacy of a Herbal Medicine Containing Pycnogenol Combined with Papain and Aloe vera in the Prevention and Management of Pre-Diabetes
title_short A Double-Blind Randomized Placebo-Controlled Study Assessing the Safety, Tolerability and Efficacy of a Herbal Medicine Containing Pycnogenol Combined with Papain and Aloe vera in the Prevention and Management of Pre-Diabetes
title_sort double-blind randomized placebo-controlled study assessing the safety, tolerability and efficacy of a herbal medicine containing pycnogenol combined with papain and aloe vera in the prevention and management of pre-diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235750/
https://www.ncbi.nlm.nih.gov/pubmed/32331307
http://dx.doi.org/10.3390/medicines7040022
work_keys_str_mv AT vitettaluis adoubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes
AT butcherbelinda adoubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes
AT dalfornoserena adoubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes
AT vitettagemma adoubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes
AT nikovtessa adoubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes
AT hallsean adoubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes
AT steelselizabeth adoubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes
AT vitettaluis doubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes
AT butcherbelinda doubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes
AT dalfornoserena doubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes
AT vitettagemma doubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes
AT nikovtessa doubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes
AT hallsean doubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes
AT steelselizabeth doubleblindrandomizedplacebocontrolledstudyassessingthesafetytolerabilityandefficacyofaherbalmedicinecontainingpycnogenolcombinedwithpapainandaloeverainthepreventionandmanagementofprediabetes